Markets:

Overview

News

Currencies

International

Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

0.3724 -0.0080 (-2.10%)

Delayed Quote Updated: 10:55 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evogene Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Evogene's Canonic Ships First Batch Of Unique Cannabis Varieties To Europe ↗

January 31, 2022

Medical grade cannabis products developer Canonic Ltd. and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has shipped the first batch of its unique cannabis varieties to Portugal, following...

Via Benzinga

Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms ↗

January 18, 2022

Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ:

Via Benzinga

Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth ↗

December 01, 2021

Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel...

Via Benzinga

Topics Cannabis

Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public Companies ↗

November 17, 2021

Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), the paren...

Via Benzinga

Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of Schedule ↗

October 19, 2021

Evogene Ltd.'s (NASDAQ:EVGN) (TASE: EVGN) whol...

Via Benzinga

Topics Cannabis

The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More ↗

November 19, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021.

Via Benzinga

Topics Cannabis

Canonic Announces Pre-Launch of Medical Cannabis Products in Israel ↗

August 31, 2021

Canonic Ltd, a company focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-...

Via Benzinga

Topics Cannabis

The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More ↗

August 13, 2021

Below is a recap of the main news related to the cannabis industry and markets for the week of August 13, 2021, which was marked by earnings report...

Via Benzinga

Topics Cannabis

Earnings Scheduled For November 17, 2021 ↗

November 17, 2021

Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is projected to report quarterly earnings at $9.25 per share on revenue of $2.77 billion....

Via Benzinga

Evogene Reports $135.000 In Q2 2021 Revenue, Misses Estimates, EPS Beat Projections By $0.02 ↗

August 11, 2021

Biotechnology company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) posted its financial results Wednesday for the first half and second quarter of 2021 along with a proclamation...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021 ↗

October 08, 2021

Upgrades UBS upgraded the previous rating for Northern Trust Corp (NASDAQ:

Via Benzinga

Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings ↗

May 26, 2021

Computational biology company Evogene Ltd. (NASDAQ:EVGN) r...

Via Benzinga

Earnings Scheduled For May 26, 2021 ↗

May 26, 2021

Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is expected to report quarterly loss at $0.14 per share on revenue of $35.05 million. • Li Auto (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 13, 2021

Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.